Mkt Cap$2.26T-1.13%
24h Vol$76.59B
BTC Dom56.1%
ETH Dom9.1%
F&G14Extreme Fear
BTC$63,171.00-1.07% ETH$1,702.93-1.72% USDT$0.9992+0.04% BNB$576.90-1.97% USDC$0.9999+0.00% XRP$1.14-1.65% SOL$69.27-2.37% TRX$0.3199+0.11% FIGR_HELOC$1.01-0.76% HYPE$68.67-2.95% DOGE$0.0832-0.88% USDS$0.9997+0.00% RAIN$0.0144-0.61% LEO$9.52-1.00% ZEC$458.09-2.82% XLM$0.2218-9.06% BTC$63,171.00-1.07% ETH$1,702.93-1.72% USDT$0.9992+0.04% BNB$576.90-1.97% USDC$0.9999+0.00% XRP$1.14-1.65% SOL$69.27-2.37% TRX$0.3199+0.11% FIGR_HELOC$1.01-0.76% HYPE$68.67-2.95% DOGE$0.0832-0.88% USDS$0.9997+0.00% RAIN$0.0144-0.61% LEO$9.52-1.00% ZEC$458.09-2.82% XLM$0.2218-9.06%
News

Earnings

Total Stories
1,219
Section
Earnings
Abbott Laboratories Reports Strong First Quarter 2025 Results and Maintains Positive Outlook
Uncategorized

Abbott Laboratories Reports Strong First Quarter Results, Maintains Positive Outlook

Abbott Laboratories reported a strong start to 2025 with significant growth in sales and EPS, exceeding market expectations.

Tim FriesApr 16, 20253 min read